...
首页> 外文期刊>Modern Pathology >Microsatellite Analysis in Post-Transplantation Lymphoproliferative Disorder to Determine Donor/Recipient Origin
【24h】

Microsatellite Analysis in Post-Transplantation Lymphoproliferative Disorder to Determine Donor/Recipient Origin

机译:移植后淋巴抑制性疾病中微卫星分析确定供体/受体的

获取原文
           

摘要

Post-transplantation lymphoproliferative disorders (PTLD) are a group of heterogeneous diseases that occur after organ transplantation. Determination of the origin of the tumor cells not only provides clues to its possible pathogenetic mechanism, but also gives prognostic guidance in the clinical management of patients. We reviewed the clinicopathological features of four cases of PTLD that developed after solid organ transplantation. Using microsatellite analysis performed on paraffin-embedded tissue and using multiple, highly polymorphic markers, we have successfully determined the recipient/donor origin of the tumor cells in all of them. The time of onset of the PTLD ranged from 5 to 11 mo. All cases were diffuse large cell lymphomas of B-cell lineage, and the two cases that have been tested for EBV by in situ hybridization were positive. Three of the 4 PTLD were of donor origin and these three patients died of diseases unrelated to PTLD. The single patient with PTLD of recipient origin died of disseminated PTLD. The mean survival length of the three patients with donor origin was 26.3 mo, whereas that of the patient with recipient origin was 12 mo. Our results indicate a relatively high incidence of PTLD of donor origin among our patients with solid organ transplantation, as compared to other reported series. Moreover, the finding of the relatively indolent nature of PTLD of donor origin supports that determination of the donor/recipient origin of PTLD is of prognostic significance.
机译:移植后淋巴抑制性疾病(PTLD)是器官移植后发生的一组异质疾病。肿瘤细胞的起源的测定不仅向其可能的致病机制提供了线索,而且还提供了患者临床管理中的预后引导。我们审查了固体器官移植后4例PTLD患者的临床病理特征。使用对石蜡包埋的组织进行微卫星分析,并使用多种高度多态性标记,我们成功地确定了所有这些肿瘤细胞的受体/供体源。 PTLD发作的时间范围为5至11月。所有病例均弥漫于B细胞谱系的大细胞淋巴瘤,并且通过原位杂交测试的两种情况下均为阳性。 4个PTLD中的三种是捐赠者来源,这三名患者死于与PTLD无关的疾病。具有PTLD的接受者源的单身患者死于传播的PTLD。捐助者源的三个患者的平均存活时间为26.3Mo,而受体引起的患者的患者为12月。与其他报告的系列相比,我们的结果表明我们的固体器官移植患者患者中的捐助者起源的PTLD发病率相对较高。此外,发现施主源的pTLD的相对惰性性质支持,施用施主/受体源的测定具有预后意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号